ArticleVaccines2026
Immunoproteomic Identification and Vaccine Assessment of
Article in Vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundAfrican animal trypanosomosis, caused by
methodsAn immunoproteomic approach was employed to identify
resultsAn invariant surface glycoprotein (Uniprot code: F9WVM3, Tritryps code: TvY486_0045500), here designated TvISGAf, was selected based on its reported diagnostic relevance and its classification within the vivaxin antigen family. The protective potential of TvISGAf was evaluated in a murine model of
conclusionsCollectively, these findings demonstrate that TvISGAf formulated with ISPA confers partial protection during acute phase of infection, consistent with the induction of trypanotolerance. These results support its potential as a promising component of a multivalent vaccine strategy against
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.